Does colorectal cancer clinical advancement affect adhesion molecules (sP- selectin, sE- selectin and ICAM-1) concentration?
Does colorectal cancer clinical advancement affect adhesion molecules (sP- selectin, sE- selectin and ICAM-1) concentration?
复制标题
DOI:
10.1016/j.thromres.2008.11.021
复制
发表时间:
2009-05-01
影响因子:
7.5
通讯作者:
Kemona, H.
中科院分区:
文献类型:
--
作者:
Dymicka-Piekarska, V.;Kemona, H.
Adhesion molecules take part in physiological and pathological processes. They involved in inflammatory reactions and play important role in tumor invasion and the development of metastases.Soluble forms of P- selectin, E- selectin and ICAM-1 have been described in this study in patient with colorectal cancer. Plasma was obtained from 44 patients with colorectal cancer and 34 control subject's prior surgery, by an enzyme- linked immunosorbent assay (ELISA). The patients were divided according to TNM classification.Plasma level of all three molecules was significantly higher in colorectal cancer patients than in the control (p < 0.001). The highest level of sE- selectin and ICAM-1 were observed in patients with liver metastasis. There was no correlation between sP- selectin and sE- selectin, but we found a significant correlation between sE- selectin and ICAM-1 in all patients.These findings suggest that plasma concentration of E- selectin and ICAM-1 may indicate tumor progression and liver metastasis. (C) 2008 Elsevier Ltd. All rights reserved.